Compare HPQ & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HPQ | FMS |
|---|---|---|
| Founded | 1939 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3B | 14.2B |
| IPO Year | 2002 | N/A |
| Metric | HPQ | FMS |
|---|---|---|
| Price | $19.37 | $22.42 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 12 | 2 |
| Target Price | $21.42 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 16.7M | 420.4K |
| Earning Date | 02-24-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.15% | 2.54% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.58 | N/A |
| Revenue | ★ $55,295,000,000.00 | N/A |
| Revenue This Year | $3.10 | $0.45 |
| Revenue Next Year | $0.39 | $3.76 |
| P/E Ratio | $33.59 | ★ $15.62 |
| Revenue Growth | ★ 3.24 | N/A |
| 52 Week Low | $17.56 | $20.96 |
| 52 Week High | $29.55 | $30.46 |
| Indicator | HPQ | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 55.94 | 46.50 |
| Support Level | $17.96 | $21.56 |
| Resistance Level | $20.09 | $24.08 |
| Average True Range (ATR) | 0.72 | 0.36 |
| MACD | 0.10 | 0.04 |
| Stochastic Oscillator | 70.43 | 47.25 |
HP (formerly Hewlett-Packard) is a behemoth in the PC and printing markets. It has focused on these markets since it exited IT infrastructure in 2015 with the split from Hewlett Packard Enterprise. HP focuses on the commercial market, but maintains sales of consumer devices and printers. The firm has a broad and global customer base, with only one third of sales coming from the US. HP completely outsources manufacturing and relies heavily on channel partners for its sales and marketing.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.